Health Innovators: Teresa Arroyo-Gallego, nQ MedicalIn this episode of our Health Innovators series, Paul Tunnah is joined by Teresa Arroyo-Gallego, chief data scientist Share XHealth Innovators: Teresa Arroyo-Gallego, nQ Medicalhttps://pharmaphorum.com/video/health-innovators-teresa-arroyo-gallego-nq-medical/
Inside MoonLake’s raid on Merck KGaA’s inflammatory disease hopeful sonelokimabSwiss biotech MoonLake Immunotherapeutics has emerged with what it hopes is one of the hottest drugs in inflammatory Share XInside MoonLake’s raid on Merck KGaA’s inflammatory disease hopeful sonelokimabhttps://pharmaphorum.com/views-and-analysis/inside-moonlakes-raid-on-merck-kgaas-inflammatory-disease-hopeful-sonelokimab/
Why relationships are key in rare disease patient engagementReal-world data is a vital part of rare disease drug development, but to get a true picture of Share XWhy relationships are key in rare disease patient engagementhttps://pharmaphorum.com/views-and-analysis/why-relationships-are-key-in-rare-disease-patient-engagement/
Tackling diabetes & ALS with cell therapyIsraeli company Kadimastem is developing regenerative medicine therapies based on differentiated cells derived from human embryonic stem cells Share XTackling diabetes & ALS with cell therapyhttps://pharmaphorum.com/views-and-analysis/tackling-diabetes-als-with-cell-therapy/
Creating a global life sciences superpower from the lessons of COVIDIt’s time to take what the UK has learnt about the “Holy Trinity” of government, academia, and industry Share XCreating a global life sciences superpower from the lessons of COVIDhttps://pharmaphorum.com/views-and-analysis/creating-a-global-life-sciences-superpower-from-the-lessons-of-covid-uk/
Collaboration is key to advancing cell therapy researchDr. Anne Kerber, VP, Head of Clinical Development, Europe at Kite, a Gilead Company, explains how the company Share XCollaboration is key to advancing cell therapy researchhttps://pharmaphorum.com/r-d/collaboration-is-key-to-advancing-cell-therapy-research/
Big data and cell therapy development: the pharmaphorum podcastIn the latest episode of the podcast pharmaphorum’s website editor Catherine Longworth speaks with Dr Darrin Disley, who’s the Share XBig data and cell therapy development: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/mogrify-big-data-cell-therapy
Clive Dix: Rebuilding UK biotechUK biotech guru Clive Dix has clinched some major deals with big pharma and biotech in the last Share XClive Dix: Rebuilding UK biotechhttps://pharmaphorum.com/views-and-analysis/clive-dix-rebuilding-uk-biotech/
The next generation of immunotherapy? Innate Pharma targets NK cellsClinical-stage oncology biotech Innate Pharma is on a mission to harness the power of natural killer cells to Share XThe next generation of immunotherapy? Innate Pharma targets NK cellshttps://pharmaphorum.com/views-and-analysis/the-next-generation-of-immunotherapy-innate-pharma/
